TY - JOUR
T1 - Mood states of patients after the diagnosis of cancer
AU - Celia, David F.
AU - Tross, Susan
AU - Orav, E. John
AU - Holland, Jimmie C.
AU - Silberfarb, Peter M.
AU - Rafla, Sameer
N1 - Funding Information:
Dr. Cella is Director of Psychological Services, Rush Cancer Center-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612. Dr. Tross is a Clinical Assistant, Psychiatry Service, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY. Dr. Orav is Assistant Professor, Department of Biostatistics, School of Public Health, Harvard Medical School, Boston, MA. Dr. Holland is Chief, Psychiatry Service, MSKCC. Dr. Silberfarb is Professor of Psychiatry and Associate Professor of Medicine, Darrmouth Medical School, Hanover, NH. Dr. Rafla is Director of Radiation Oncology, Methodist Hospital, Brooklyn, NY. Participants for the study described were treated in the Cancer and Leukemia Group B (CALGB) protocol chaired by Drs. M. R. Cooper and 0. R. McIntyre (CALGB 7761); L. H. Maurer (CALGB 7781); R. L. Comis, P. S. Schein, and D. F. Hoth (CALGB 7981 and 7982); and M. C. Perry (CALGB 8083). The study was conducted by the CALGB and was supported by Public Health Service grants from the National Cancer Institute, the National Institutes of Health, and the Department of Health and Human Services and by a grant from the T. J. Martell Foundation for Leukemia and Cancer Research.
PY - 1989/7/6
Y1 - 1989/7/6
N2 - Data on the widely used Profile of Mood States (POMS) are presented for 923 recently diagnosed, previously untreated cancer patients. The patients’ responses to the POMS were significantly different from those of other groups on which normative data are currently available. Therefore, the authors recommend that investigators who are conducting empirical studies of mood in patients with cancer use the tables in this article rather than previously published test norms on college students and psychotherapy patients.
AB - Data on the widely used Profile of Mood States (POMS) are presented for 923 recently diagnosed, previously untreated cancer patients. The patients’ responses to the POMS were significantly different from those of other groups on which normative data are currently available. Therefore, the authors recommend that investigators who are conducting empirical studies of mood in patients with cancer use the tables in this article rather than previously published test norms on college students and psychotherapy patients.
UR - http://www.scopus.com/inward/record.url?scp=0024405514&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024405514&partnerID=8YFLogxK
U2 - 10.1300/J077v07n01_04
DO - 10.1300/J077v07n01_04
M3 - Article
AN - SCOPUS:0024405514
SN - 0734-7332
VL - 7
SP - 45
EP - 54
JO - Journal of Psychosocial Oncology
JF - Journal of Psychosocial Oncology
IS - 1-2
ER -